Comparative Study of Blood-Based Biomarkers, α2,3-Sialic Acid PSA and PHI, for High-Risk Prostate Cancer Detection

Prostate Specific Antigen (PSA) is the most commonly used serum marker for prostate cancer (PCa), although it is not specific and sensitive enough to allow the differential diagnosis of the more aggressive tumors. For that, new diagnostic methods are being developed, such as PCA-3, PSA isoforms that...

Descripción completa

Detalles Bibliográficos
Autores principales: Ferrer-Batallé, Montserrat, Llop, Esther, Ramírez, Manel, Aleixandre, Rosa Núria, Saez, Marc, Comet, Josep, de Llorens, Rafael, Peracaula, Rosa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2017
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5412429/
https://www.ncbi.nlm.nih.gov/pubmed/28420168
http://dx.doi.org/10.3390/ijms18040845

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5412429/
https://www.ncbi.nlm.nih.gov/pubmed/28420168
http://dx.doi.org/10.3390/ijms18040845

Ejemplares similares